There has been a lot of hype concerning what has been dubbed Cannabis 2.0 in Canada, as the country legalized a variety of derivatives that are expected to...
The perception of cannabis has changed significantly over the last decade. While in the not too distant past, weed was associated with an alternative...
Even prior to the horrible September quarterly report, analysts were questioning the cash position of Aurora Cannabis (ACB). A big part of the problem was a...
The U.S. Food and Drug Association has crushed investor hopes for substantial growth in cannabidol (CBD) sales. The government organization doubled down on...
Last week saw a landmark decision by the U.S. House Judiciary Committee, which approved a bill advocating the decriminalization of marijuana at the federal...
Aurora Cannabis (ACB) stock took a beating since the latest earnings report, when it announced a 24 percent decline in net revenue sequentially, which included...
The Q3 earnings reports in the cannabis sector provided the first clear separation between the U.S. and Canadian players. While most of the U.S. multi-state...
Even after a sector bounce the last couple of days, the Canadian cannabis sector is down substantially for the year. The Canadian cannabis sales haven’t...
After a horrendous quarter, Canopy Growth (CGC) fell to new yearly lows below $14. The stock has rallied substantially in the last couple of days as the market...
The vast majority of the Canadian cannabis sector gets beaten down almost every day. The Canadian cannabis sales aren’t living up to expectations after...
